CN113826799A - 减肥用食品 - Google Patents
减肥用食品 Download PDFInfo
- Publication number
- CN113826799A CN113826799A CN202111126552.3A CN202111126552A CN113826799A CN 113826799 A CN113826799 A CN 113826799A CN 202111126552 A CN202111126552 A CN 202111126552A CN 113826799 A CN113826799 A CN 113826799A
- Authority
- CN
- China
- Prior art keywords
- powder
- weight
- food
- inulin
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 29
- 235000005911 diet Nutrition 0.000 title claims description 11
- 230000037213 diet Effects 0.000 title claims description 11
- 239000000843 powder Substances 0.000 claims abstract description 59
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 20
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 20
- 229920001202 Inulin Polymers 0.000 claims abstract description 19
- 229940029339 inulin Drugs 0.000 claims abstract description 19
- 239000003094 microcapsule Substances 0.000 claims abstract description 19
- 238000001035 drying Methods 0.000 claims abstract description 14
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 12
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims abstract description 12
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 11
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 11
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 11
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 11
- 239000010903 husk Substances 0.000 claims abstract description 11
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 10
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims abstract description 10
- 229940054810 white kidney bean extract Drugs 0.000 claims abstract description 10
- 241000219357 Cactaceae Species 0.000 claims abstract description 9
- 235000014443 Pyrus communis Nutrition 0.000 claims abstract description 9
- 239000007787 solid Substances 0.000 claims abstract description 9
- 239000011259 mixed solution Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 21
- 230000001603 reducing effect Effects 0.000 abstract description 12
- 239000003814 drug Substances 0.000 abstract description 9
- 229940126673 western medicines Drugs 0.000 abstract description 3
- 230000009982 effect on human Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 235000013325 dietary fiber Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 239000003392 amylase inhibitor Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 244000134552 Plantago ovata Species 0.000 description 3
- 235000003421 Plantago ovata Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000013585 weight reducing agent Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000015728 Mucins Human genes 0.000 description 2
- 108010063954 Mucins Proteins 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- APRYNIRZSROXCQ-UHFFFAOYSA-N 3-ethyl-2-nitrophenol Chemical compound CCC1=CC=CC(O)=C1[N+]([O-])=O APRYNIRZSROXCQ-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 240000009297 Opuntia ficus-indica Species 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 229960001058 bupropion Drugs 0.000 description 1
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000037219 healthy weight Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960002847 prasterone Drugs 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明属于食品领域，尤其是涉及减肥用食品，按照重量份包括以下成分：圆苞车前子壳粉1‑5g、中联甘油三酯微囊粉1‑5g、阿拉伯糖1‑5g、菊粉1‑5g、香蕉粉1‑5g、左旋肉碱微囊粉0.7‑1.1g、白芸豆提取物0.2‑0.6g、金针菇粉0.1‑0.5g、梨果仙人掌粉0.26‑0.34g、马铃薯提取物0.06‑0.14g,助干剂0.4‑0.8g。本发明立足于传统中医理论，鉴于通过西药进行减肥，副作用大，通过传统方式食用中药的方式，较为不便且不易推广的难题，通过将多种抗糖减脂成分组合起来，并生产制造成较易为人群所接受的固体饮料状食品，各成分之间相互配合，不仅不有较好的减肥降脂功效，且对人体具有一定的养生保健效果，便于推广使用，且无毒副作用，且见效快，对于不同年龄段的人群均适用。
Description
技术领域
本发明属于食品领域，尤其是涉及减肥用食品。
背景技术
随着人们经济水平的快速提高，随之而来的健康问题也日渐突出，其中肥胖作为一种亚健康状态困扰着许多人，不仅仅影响个人的外在形象，同时会严重影响个人的身体与心理健康。为提高个人外在形象，保持健康的体魄，许多人自觉接受减肥，但由于缺乏意志力与持续的坚持，“减肥”成为人们日益关注的重难点问题。
一般通过西药进行减肥主要分为以下几种：消耗剂(如甲状腺激素类、乙硝基酚、生长激素等)、消化吸收剂(新霉素、α－淀粉酶抑制剂)、抑制剂(苯丙胺类、双胍类降糖药、安非拉酮)、脂质代谢药(羟柠檬酸盐和脱氢异雄酮)等，但由于对人体会有一定的伤害和副作用，被很多人所诟病。而中药从健脾、益气、化痰着手，通过对求美者身体的内部机能进行调节，恢复人体各个器官的正常的功能，从而达到正常的燃烧多余的脂肪，达到健康减肥的最终目的，同时中药减肥还能够促进人体的新陈代谢，中医一般认为，肥胖与人体的痰、湿、气血等有很大的关系，所以重要从调理人体的内在机能着手，达到使得人体的新陈代谢加快，从而避免脂肪堆积在体内，使得脂肪燃烧，达到减脂的目的。所以中药减肥方法不仅仅能够减肥，而且可以帮助调理脏腑和内分泌，使得身体整个机体的运动趋于正常，能够将身体内的废物和多余的水分等排出体外，从而达到身体快速瘦下来的目的。但传统的中药对于一般人而言，味道和口感较难接受，且不便于服用，影响消费者的使用。
为此，我们提出减肥用食品来解决上述问题。
发明内容
本发明的目的是针对上述问题，提供便于使用，较易被消费者接受和使用的减肥用食品。
为达到上述目的，本发明采用了下列技术方案：减肥用食品，按照重量份包括以下成分：圆苞车前子壳粉1-5g、中联甘油三酯微囊粉1-5g、阿拉伯糖1-5g、菊粉1-5g、香蕉粉1-5g、左旋肉碱微囊粉0.9-1.1g、白芸豆提取物0.2-0.6g、金针菇粉0.1-0.5g、梨果仙人掌粉0.26-0.34g、马铃薯提取物0.06-0.14g,助干剂0.4-0.8g。
在上述的减肥用食品中，减肥用食品的加工方法包括以下步骤：
S1、将相应重量份的原料进行混合、搅拌得混合液；
S2、对混合液进行减压浓缩至固体约为20％,添加助干剂，喷雾干燥得固体饮料。
在上述的减肥用食品中，所述助干剂为药用糊精。
在上述的减肥用食品中，所述S2中，喷雾干燥的目标温度为140-165℃。
与现有的技术相比，本减肥用食品的优点在于：本发明立足于传统中医理论，鉴于通过西药进行减肥，副作用大，通过传统方式食用中药的方式，较为不便且不易推广的难题，通过将多种抗糖减脂成分组合起来，并生产制造成较易为人群所接受的固体饮料状食品，各原料成分之间相互配合，不仅不有较好的减肥降脂功效，且对人体具有一定的养生保健效果，便于推广使用，且无毒副作用，且见效快，对于不同年龄段的人群均适用。
具体实施方式
以下实施例仅处于说明性目的，而不是想要限制本发明的范围。
实施例1
减肥用食品，包括圆苞车前子壳粉1g、中联甘油三酯微囊粉2g、阿拉伯糖3g、菊粉4g、香蕉粉5g、左旋肉碱微囊粉1.1g、白芸豆提取物0.6g、金针菇粉0.1g、梨果仙人掌粉0.34g、马铃薯提取物0.06g,助干剂0.4g。
实施例2
本实施例与以上实施例的不同之处在于：圆苞车前子壳粉2g、中联甘油三酯微囊粉3g、阿拉伯糖4g、菊粉5g、香蕉粉1g、左旋肉碱微囊粉1g、白芸豆提取物0.5g、金针菇粉0.2g、梨果仙人掌粉0.32g、马铃薯提取物0.08g,助干剂0.5g。
实施例3
本实施例与以上实施例的不同之处在于：圆苞车前子壳粉3g、中联甘油三酯微囊粉4g、阿拉伯糖5g、菊粉1g、香蕉粉2g、左旋肉碱微囊粉0.9g、白芸豆提取物0.4g、金针菇粉0.3g、梨果仙人掌粉0.3g、马铃薯提取物0.1g,助干剂0.6g。
实施例4
本实施例与以上实施例的不同之处在于：圆苞车前子壳粉4g、中联甘油三酯微囊粉5g、阿拉伯糖1g、菊粉2g、香蕉粉3g、左旋肉碱微囊粉0.8g、白芸豆提取物0.3g、金针菇粉0.4g、梨果仙人掌粉0.28g、马铃薯提取物0.12g,助干剂0.7g。
实施例5
本实施例与以上实施例的不同之处在于：圆苞车前子壳粉5g、中联甘油三酯微囊粉1g、阿拉伯糖2g、菊粉3g、香蕉粉4g、左旋肉碱微囊粉0.7g、白芸豆提取物0.2g、金针菇粉0.5g、梨果仙人掌粉0.26g、马铃薯提取物0.14g,助干剂0.8g。
减肥用食品的加工方法包括以下步骤：
S1、将相应重量份的原料进行混合、搅拌得混合液；
S2、对混合液进行减压浓缩至固体约为20％,添加助干剂，喷雾干燥得固体饮料。
助干剂为药用糊精，S2中，喷雾干燥的目标温度为140-165℃。
各组分原料的功效如下：
圆苞车前子壳粉：富含膳食纤维，高达80％以上，而其中可溶性膳食纤维与不溶性膳食纤维的比例高达7:3。其他营养成分主要包括葡萄糖甙、蛋白质、多糖、维生素B1和胆碱。圆苞车前子壳粉具有减肥的功效，它能够有助于帮助人们比较好的去阻断脂肪的吸收和利用，同时能够促进益生菌的生长，可以起到润肠通便的功效，能够有助于减少糖尿病对胰岛素的需求，也能够有助于帮助人们修复受到损伤的胰岛素细胞，同时可以帮助人们预防和减少心血管疾病。
中联甘油三酯微囊粉：能给人体迅速供能，在肝脏中代谢，它不会成为贮存脂肪而只是产生能量，所以通过摄入MCT代替部分常规油脂就可以控制能量摄入和贮备，达到控制体重的目的。
阿拉伯糖：阿拉伯糖能够抑止人体肠道内绵白糖酶的活性，具备抑止绵白糖消化吸收的作用；除此之外，L-阿拉伯糖还能够抑止人体人体脂肪沉积，因此可被用以预防肥胖症、高血压、高血脂等病症。
菊粉：菊粉是一种天然的水溶性膳食纤维，几乎不能被胃酸水解和消化，只有在结肠被有益微生物利用，从而改善肠道环境。研究表明，双歧杆菌的增殖程度取决于人体大肠中初始双歧杆菌的数量，当初始双歧杆菌数量减少时，使用菊粉后增殖效果明显，当初始双歧杆菌的数量多时，使用菊粉后效果并不明显。其次，摄入菊粉后能增强胃肠道蠕动，提高肠胃功能，增加消化和食欲，提高机体免疫力。防便秘及治疗肥胖症膳食纤维减少食物在胃肠的停留时间，以及增加粪便量，有效地治疗便秘。其减肥作用是提高内容物的黏度，降低食物从胃进入小肠的速度，从而降低饥饿感，减少食物的摄食量。
香蕉粉：，香蕉粉可以使血糖持续平稳上升和下降。既不会造成胰岛素大量分泌，又增加了饱腹感持续时间，具有降血压、助消化等功效。
左旋肉碱微囊粉：左旋肉碱微囊粉是优良的减肥活性物质，是膳食的正常成分，其主要功能是帮助长链脂肪酸进行脂肪酸的β-氧化，可将体内多余的脂肪酸及其他脂肪酸的残留物以酯酰基形式从线粒体膜外转移到膜内，使细胞内的能量平衡，有利于人体对脂肪的利用，有利于人体对脂肪的利用，包括燃烧多余的脂肪用作能量，且对身体无副作用，同时注意加强锻炼，将体内积累的脂肪消耗，起到减肥作用。
白芸豆提取物：白芸豆中的α-淀粉酶抑制剂能够彻底阻断底物与α-淀粉酶活性位点之间相互作用的通道，使得人体口腔、胰腺里的α-淀粉酶活力下降，淀粉不能完全被分解成小分子的单糖被人体吸收，从而达到控制淀粉转化为卡路里被摄入。
金针菇粉：可抑制血脂升高，降低胆固醇，防治心脑血管疾病；常食用金针菇，不仅可以预防和治疗肝脏病及胃、肠道溃疡，是一种高钾低钠食品，金针菇的蛋白质含量很高，其中含有18种氨基酸，有8种是人体必需的，氨基酸总量占金针菇干重的20％左右，其中的赖氨酸特别有利于骨骼健康，而富含的精氨酸则有利于防治肝脏疾病和胃溃疡的功效。
梨果仙人掌粉：其主要原料是天然植物梨果仙人掌，可以通过基因和代谢途径抑制脂肪的积累和形成，可以减少油脂的吸收和分解当餐的油脂并排出，从而达到辅助瘦身的效果。
马铃薯提取物：含丰富的蛋白质、粗纤维、碳水化合物，能为人类提供有益的营养元素，土豆蛋白含有大量粘体蛋白质，粘体蛋白质是一种多糖蛋白的混合物，能预防心血管系统的脂肪沉积，保持动脉血管的弹性，防止动脉粥样化的过早发生，还可防止肝、肾中结缔组织的萎缩，保持呼吸道和消化道的润滑。
同时，圆苞车前子壳粉与菊粉相互配合：圆苞车前子进入肠道吸水后会形成8～14倍体积的凝胶团,能维持粪便的水分和柔软度,而凝胶团也会刺激肠壁产生反射性收缩作用,而促进肠道正常的排空，但圆苞车前子壳中所带羟基或羧基等支链会与某些矿物元素结合影响人体肠道内矿物质代谢平衡；菊粉仅能被大肠中有益菌所消化利用.添加菊粉可以使食品向低糖、低脂肪、高膳食纤维的方向转化,同时又可以尽量保持食品的原有风味不受影响,这使得菊粉易被消费者接受。而且菊粉对健康也大有裨益。菊粉有助于控制血糖水平,降低胆固醇的量。菊粉的代谢产物可促进B族维生素及叶酸的合成,提高机体的新陈代谢,提高免疫力和抗病力，这一点正好弥补了圆苞车前子壳粉的不足之处，两者相互配合，可达到较好的降脂减肥功效，同时不影响人体正常代谢。
进一步的，阿拉伯糖与白芸豆相互配合：通过阿拉伯糖抑制消化道内蔗糖酶的作用，从而降低蔗糖在消化道内被分解和吸收，减少了食物中蔗糖的吸收；并通过白芸豆提取物的主要活性成分α-淀粉酶抑制剂，抑制淀粉和其他碳水化合物被分解成为葡萄糖，从而减少吸收，二者复合配比可以充分发挥各自的酶抑制剂优势，从而起到减少多余能量的摄入，防止过多能量转化成为脂肪，起到更好的减肥降脂效果。
以上所述仅为本发明的较佳实施例，并不用以限制本发明，凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (4)
1.减肥用食品，其特征在于，按照重量份包括以下成分：圆苞车前子壳粉1-5g、中联甘油三酯微囊粉1-5g、阿拉伯糖1-5g、菊粉1-5g、香蕉粉1-5g、左旋肉碱微囊粉0.7-1.1g、白芸豆提取物0.2-0.6g、金针菇粉0.1-0.5g、梨果仙人掌粉0.26-0.34g、马铃薯提取物0.06-0.14g,助干剂0.4-0.8g。
2.根据权利要求1所述的减肥用食品的加工方法包括以下步骤：
S1、将相应重量份的原料进行混合、搅拌得混合液；
S2、对混合液进行减压浓缩至固体约为20％,添加助干剂，喷雾干燥得固体饮料。
3.根据权利要求2所述的减肥用食品，其特征在于，所述助干剂为药用糊精。
4.根据权利要求2所述的减肥用食品，其特征在于，所述S2中，喷雾干燥的目标温度为140-165℃。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111126552.3A CN113826799A (zh) | 2021-09-26 | 2021-09-26 | 减肥用食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111126552.3A CN113826799A (zh) | 2021-09-26 | 2021-09-26 | 减肥用食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113826799A true CN113826799A (zh) | 2021-12-24 |
Family
ID=78970130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111126552.3A Pending CN113826799A (zh) | 2021-09-26 | 2021-09-26 | 减肥用食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113826799A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114343099A (zh) * | 2022-01-11 | 2022-04-15 | 山东中大药业有限公司 | 一种l-阿拉伯糖膳食纤维固体饮料及其制备方法 |
| CN114424825A (zh) * | 2022-04-02 | 2022-05-03 | 中科宜康（北京）生物科技有限公司 | 五重减脂组合物及其制备方法和应用 |
| CN115997930A (zh) * | 2023-01-13 | 2023-04-25 | 时代生物科技（深圳）有限公司 | 一种具有减脂功能的组合物及其制备方法 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000021391A1 (en) * | 1998-10-09 | 2000-04-20 | Sanacare Aps | Diet food |
| US20080187606A1 (en) * | 2001-12-12 | 2008-08-07 | Min-Young Kim | Antiobesity composition |
| CN102366093A (zh) * | 2011-09-22 | 2012-03-07 | 唐传生物科技（厦门）有限公司 | 一种复合减肥保健食品 |
| CN105795468A (zh) * | 2016-01-08 | 2016-07-27 | 天津天狮生物发展有限公司 | 一种具有减肥功效的组合物 |
| CN108719987A (zh) * | 2018-05-25 | 2018-11-02 | 生命说（北京）健康管理有限公司 | 一种全营养减肥食品及其制备方法 |
| CN109222101A (zh) * | 2018-11-29 | 2019-01-18 | 汤臣倍健股份有限公司 | 具有减肥功效的组合物及保健食品 |
| CN109601916A (zh) * | 2018-12-28 | 2019-04-12 | 中泰宜佳健康科技（北京）有限责任公司 | 一种减肥代餐组合物及其制备方法 |
| CN112741320A (zh) * | 2021-01-11 | 2021-05-04 | 杭州佰倍优生物科技有限公司 | 一种减肥组合物及其制备方法和应用 |
-
2021
- 2021-09-26 CN CN202111126552.3A patent/CN113826799A/zh active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000021391A1 (en) * | 1998-10-09 | 2000-04-20 | Sanacare Aps | Diet food |
| US20080187606A1 (en) * | 2001-12-12 | 2008-08-07 | Min-Young Kim | Antiobesity composition |
| CN101277710A (zh) * | 2005-10-05 | 2008-10-01 | 血管实验室公司 | 减肥组成物 |
| CN102366093A (zh) * | 2011-09-22 | 2012-03-07 | 唐传生物科技（厦门）有限公司 | 一种复合减肥保健食品 |
| CN105795468A (zh) * | 2016-01-08 | 2016-07-27 | 天津天狮生物发展有限公司 | 一种具有减肥功效的组合物 |
| CN108719987A (zh) * | 2018-05-25 | 2018-11-02 | 生命说（北京）健康管理有限公司 | 一种全营养减肥食品及其制备方法 |
| CN109222101A (zh) * | 2018-11-29 | 2019-01-18 | 汤臣倍健股份有限公司 | 具有减肥功效的组合物及保健食品 |
| CN109601916A (zh) * | 2018-12-28 | 2019-04-12 | 中泰宜佳健康科技（北京）有限责任公司 | 一种减肥代餐组合物及其制备方法 |
| CN112741320A (zh) * | 2021-01-11 | 2021-05-04 | 杭州佰倍优生物科技有限公司 | 一种减肥组合物及其制备方法和应用 |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114343099A (zh) * | 2022-01-11 | 2022-04-15 | 山东中大药业有限公司 | 一种l-阿拉伯糖膳食纤维固体饮料及其制备方法 |
| CN114343099B (zh) * | 2022-01-11 | 2024-03-26 | 山东中大药业有限公司 | 一种l-阿拉伯糖膳食纤维固体饮料及其制备方法 |
| CN114424825A (zh) * | 2022-04-02 | 2022-05-03 | 中科宜康（北京）生物科技有限公司 | 五重减脂组合物及其制备方法和应用 |
| CN115997930A (zh) * | 2023-01-13 | 2023-04-25 | 时代生物科技（深圳）有限公司 | 一种具有减脂功能的组合物及其制备方法 |
| CN115997930B (zh) * | 2023-01-13 | 2024-04-05 | 时代生物科技（深圳）有限公司 | 一种具有减脂功能的组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113826799A (zh) | 减肥用食品 | |
| US5612039A (en) | Dietary supplement | |
| CN106690290A (zh) | 一种高膳食纤维全营养特殊医学用途配方食品及其制备方法 | |
| CN108685100B (zh) | 一种复合短肽粉配方及其制备方法 | |
| CN107319525A (zh) | 一种减肥减脂专用型临床营养配方及其制备方法 | |
| CN102113648A (zh) | 一种适合“五高”代谢综合症人群的特膳面条及其制备方法 | |
| CN109170459A (zh) | 一种蛋白谷物果蔬粉固体饮料及制备方法 | |
| CN104856003A (zh) | 糖尿病非全营养配方食品 | |
| CN110810845A (zh) | 一种具有生酮、减脂、抗糖功能的全营养配方粉及其应用 | |
| CN109221898A (zh) | 一种含低聚木糖的谷物粉及其制备方法和应用 | |
| CN107616490A (zh) | 一种儿童术后专用型临床营养配方及其制备方法 | |
| CN104839664A (zh) | 骨质疏松医学配方食品 | |
| CN106690331A (zh) | 一种海带膳食纤维颗粒及其制备方法 | |
| CN106723087A (zh) | 一种含海带膳食纤维的片剂及其制备方法 | |
| CN104855985A (zh) | 尿酸高非全营养配方食品 | |
| CN104855994A (zh) | 肾病非全营养配方食品 | |
| CN104839707A (zh) | 阴虚体质非全营养配方食品 | |
| CN107198246A (zh) | 一种保健组合物与一种保健制剂 | |
| CN102113652A (zh) | 一种适合“五高”代谢综合症人群的特膳挤压米及其制备方法 | |
| CN101238893A (zh) | 一种高膳食纤维鹰嘴豆营养粉及其制备方法和用途 | |
| CN111543605A (zh) | 一种四高或肥胖人群用综合营养粉 | |
| CN110710660A (zh) | 含有苦瓜粉的降低血糖组合物及膳食补充剂 | |
| CN104839678A (zh) | 肾病医学配方食品 | |
| CN104839655A (zh) | 降三高壮阳医学配方食品 | |
| CN108713755A (zh) | 藜麦瘦身营养奶昔 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211224 |